ABOS (Acumen Pharmaceuticals) Short Ratio


ABOS Acumen Pharmaceuticals Inc ABOS
34 GF Score
Price $2.77
! 3 Warning Signs
View Full Analysis

What is Acumen Pharmaceuticals Short Ratio?

Short Ratio is a metric signaling prevailing investors' sentiment with a company. It represents the number of days it takes short sellers on average to repurchase all the shares short.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

ABOS
34GF Score
Acumen Pharmaceuticals Inc ABOS
Short Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Acumen Pharmaceuticals Business Description

Address 1210-1220 Washington Street, Suite 210, Newton, MA, USA, 02465
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers. The product pipelines include: ALTITUDE-AD; and INTERCEPT-AD.
34GF Score

Get the complete analysis for ABOS

Short Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.77
Price